THIS IS OUTDATED. All documentation is now on the github wiki. Please refer there or to the CDM working group for more information
The RELATIONSHIP table provides a reference list of all types of relationships that can be used to associate any two concepts in the CONCEPT_RELATIONSHP table.
| Field | Required | Type | Description |
|---|---|---|---|
| relationship_id | Yes | varchar(20) | The type of relationship captured by the relationship record. |
| relationship_name | Yes | varchar(255) | The text that describes the relationship type. |
| is_hierarchical | Yes | varchar(1) | Defines whether a relationship defines concepts into classes or hierarchies. Values are 1 for hierarchical relationship or 0 if not. |
| defines_ancestry | Yes | varchar(1) | Defines whether a hierarchical relationship contributes to the concept_ancestor table. These are subsets of the hierarchical relationships. Valid values are 1 or 0. |
| reverse_relationship_id | Yes | varchar(20) | The identifier for the relationship used to define the reverse relationship between two concepts. |
| relationship_concept_id | Yes | integer | A foreign key that refers to an identifier in the CONCEPT table for the unique relationship concept. |
| relationship_id previously | relationship_id Version 5 |
|---|---|
| 1 | LOINC replaced by |
| 2 | Has precise ing |
| 3 | Has tradename |
| 4 | RxNorm has dose form |
| 5 | Has form |
| 6 | RxNorm has ing |
| 7 | Constitutes |
| 8 | Contains |
| 9 | Reformulation of |
| 10 | Subsumes |
| 11 | NDFRT has dose form |
| 12 | Induces |
| 13 | May diagnose |
| 14 | Has physio effect |
| 15 | Has CI physio effect |
| 16 | NDFRT has ing |
| 17 | Has CI chem class |
| 18 | Has MoA |
| 19 | Has CI MoA |
| 20 | Has PK |
| 21 | May treat |
| 22 | CI to |
| 23 | May prevent |
| 24 | Has metabolites |
| 25 | Has metabolism |
| 26 | May be inhibited by |
| 27 | Has chem structure |
| 28 | NDFRT - RxNorm eq |
| 29 | Has recipient cat |
| 30 | Has proc site |
| 31 | Has priority |
| 32 | Has pathology |
| 33 | Has part of |
| 34 | Has severity |
| 35 | Has revision status |
| 36 | Has access |
| 37 | Has occurrence |
| 38 | Has method |
| 39 | Has laterality |
| 40 | Has interprets |
| 41 | Has indir morph |
| 42 | Has indir device |
| 43 | Has specimen |
| 44 | Has interpretation |
| 45 | Has intent |
| 46 | Has focus |
| 47 | Has manifestation |
| 48 | Has active ing |
| 49 | Has finding site |
| 50 | Has episodicity |
| 51 | Has dir subst |
| 52 | Has dir morph |
| 53 | Has dir device |
| 54 | Has component |
| 55 | Has causative agent |
| 56 | Has asso morph |
| 57 | Has asso finding |
| 58 | Has measurement |
| 59 | Has property |
| 60 | Has scale type |
| 61 | Has time aspect |
| 62 | Has specimen proc |
| 63 | Has specimen source |
| 64 | Has specimen morph |
| 65 | Has specimen topo |
| 66 | Has specimen subst |
| 67 | Has due to |
| 68 | Has relat context |
| 69 | Has dose form |
| 70 | Occurs after |
| 71 | Has asso proc |
| 72 | Has dir proc site |
| 73 | Has indir proc site |
| 74 | Has proc device |
| 75 | Has proc morph |
| 76 | Has finding context |
| 77 | Has proc context |
| 78 | Has temporal context |
| 79 | Findinga sso with |
| 80 | Has surgical appr |
| 81 | Using device |
| 82 | Using energy |
| 83 | Using subst |
| 84 | Using acc device |
| 85 | Has clinical course |
| 86 | Has route of admin |
| 87 | Using finding method |
| 88 | Using finding inform |
| 92 | ICD9P - SNOMED eq |
| 93 | CPT4 - SNOMED cat |
| 94 | CPT4 - SNOMED eq |
| 125 | MedDRA - SNOMED eq |
| 126 | Has FDA-appr ind |
| 127 | Has off-label ind |
| 129 | Has CI |
| 130 | ETC - RxNorm |
| 131 | ATC - RxNorm |
| 132 | SMQ - MedDRA |
| 135 | LOINC replaces |
| 136 | Precise ing of |
| 137 | Tradename of |
| 138 | RxNorm dose form of |
| 139 | Form of |
| 140 | RxNorm ing of |
| 141 | Consists of |
| 142 | Contained in |
| 143 | Reformulated in |
| 144 | Is a |
| 145 | NDFRT dose form of |
| 146 | Induced by |
| 147 | Diagnosed through |
| 148 | Physiol effect by |
| 149 | CI physiol effect by |
| 150 | NDFRT ing of |
| 151 | CI chem class of |
| 152 | MoA of |
| 153 | CI MoA of |
| 154 | PK of |
| 155 | May be treated by |
| 156 | CI by |
| 157 | May be prevented by |
| 158 | Metabolite of |
| 159 | Metabolism of |
| 160 | Inhibits effect |
| 161 | Chem structure of |
| 162 | RxNorm - NDFRT eq |
| 163 | Recipient cat of |
| 164 | Proc site of |
| 165 | Priority of |
| 166 | Pathology of |
| 167 | Part of |
| 168 | Severity of |
| 169 | Revision status of |
| 170 | Access of |
| 171 | Occurrence of |
| 172 | Method of |
| 173 | Laterality of |
| 174 | Interprets of |
| 175 | Indir morph of |
| 176 | Indir device of |
| 177 | Specimen of |
| 178 | Interpretation of |
| 179 | Intent of |
| 180 | Focus of |
| 181 | Manifestation of |
| 182 | Active ing of |
| 183 | Finding site of |
| 184 | Episodicity of |
| 185 | Dir subst of |
| 186 | Dir morph of |
| 187 | Dir device of |
| 188 | Component of |
| 189 | Causative agent of |
| 190 | Asso morph of |
| 191 | Asso finding of |
| 192 | Measurement of |
| 193 | Property of |
| 194 | Scale type of |
| 195 | Time aspect of |
| 196 | Specimen proc of |
| 197 | Specimen identity of |
| 198 | Specimen morph of |
| 199 | Specimen topo of |
| 200 | Specimen subst of |
| 201 | Due to of |
| 202 | Relat context of |
| 203 | Dose form of |
| 204 | Occurs before |
| 205 | Asso proc of |
| 206 | Dir proc site of |
| 207 | Indir proc site of |
| 208 | Proc device of |
| 209 | Proc morph of |
| 210 | Finding context of |
| 211 | Proc context of |
| 212 | Temporal context of |
| 213 | Asso with finding |
| 214 | Surgical appr of |
| 215 | Device used by |
| 216 | Energy used by |
| 217 | subst used by |
| 218 | Acc device used by |
| 219 | Clinical course of |
| 220 | Route of admin of |
| 221 | Finding method of |
| 222 | Finding inform of |
| 226 | SNOMED - ICD9P eq |
| 227 | SNOMED cat - CPT4 |
| 228 | SNOMED - CPT4 eq |
| 239 | SNOMED - MedDRA eq |
| 240 | Is FDA-appr ind of |
| 241 | Is off-label ind of |
| 243 | Is CI of |
| 244 | RxNorm - ETC |
| 245 | RxNorm - ATC |
| 246 | MedDRA - SMQ |
| 247 | Ind/CI - SNOMED |
| 248 | SNOMED - ind/CI |
| 275 | Has therap class |
| 276 | Therap class of |
| 277 | Drug-drug inter for |
| 278 | Has drug-drug inter |
| 279 | Has pharma prep |
| 280 | Pharma prep in |
| 281 | Inferred class of |
| 282 | Has inferred class |
| 283 | SNOMED proc - HCPCS |
| 284 | HCPCS - SNOMED proc |
| 285 | RxNorm - NDFRT name |
| 286 | NDFRT - RxNorm name |
| 287 | ETC - RxNorm name |
| 288 | RxNorm - ETC name |
| 289 | ATC - RxNorm name |
| 290 | RxNorm - ATC name |
| 291 | HOI - SNOMED |
| 292 | SNOMED - HOI |
| 293 | DOI - RxNorm |
| 294 | RxNorm - DOI |
| 295 | HOI - MedDRA |
| 296 | MedDRA - HOI |
| 297 | NUCC - CMS Specialty |
| 298 | CMS Specialty - NUCC |
| 299 | DRG - MS-DRG eq |
| 300 | MS-DRG - DRG eq |
| 301 | DRG - MDC cat |
| 302 | MDC cat - DRG |
| 303 | Visit cat - PoS |
| 304 | PoS - Visit cat |
| 305 | VAProd - NDFRT |
| 306 | NDFRT - VAProd |
| 307 | VAProd - RxNorm eq |
| 308 | RxNorm - VAProd eq |
| 309 | RxNorm replaced by |
| 310 | RxNorm replaces |
| 311 | SNOMED replaced by |
| 312 | SNOMED replaces |
| 313 | ICD9P replaced by |
| 314 | ICD9P replaces |
| 315 | Multilex has ing |
| 316 | Multilex ing of |
| 317 | RxNorm - Multilex eq |
| 318 | Multilex - RxNorm eq |
| 319 | Multilex ing - class |
| 320 | Class - Multilex ing |
| 321 | Maps to |
| 322 | Mapped from |
| 325 | Map includes child |
| 326 | Included in map from |
| 327 | Map excludes child |
| 328 | Excluded in map from |
| 345 | UCUM replaced by |
| 346 | UCUM replaces |
| 347 | Concept replaced by |
| 348 | Concept replaces |
| 349 | Concept same_as to |
| 350 | Concept same_as from |
| 351 | Concept alt_to to |
| 352 | Concept alt_to from |
| 353 | Concept poss_eq to |
| 354 | Concept poss_eq from |
| 355 | Concept was_a to |
| 356 | Concept was_a from |
| 357 | SNOMED meas - HCPCS |
| 358 | HCPCS - SNOMED meas |
| 359 | Domain subsumes |
| 360 | Is domain |